Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3gfe | P37 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.620 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.604 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.604 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.598 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.584 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.579 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.573 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.569 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.565 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.563 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.558 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.556 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.554 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.551 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.551 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.549 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.542 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.542 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.541 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.540 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.539 | |
| 2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.535 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.531 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.529 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.525 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.524 | |
| 2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.522 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3fsf | FSS | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.519 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.514 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.513 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.513 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 3fml | FML | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.510 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.508 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.507 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.507 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.506 | |
| 1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3bv2 | P38 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.504 | |
| 3rin | I2O | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.503 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.503 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.503 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.501 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.501 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.499 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.494 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.494 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.493 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.493 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.490 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.489 | |
| 1t0l | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.489 | |
| 3fkn | FKN | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.488 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.488 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.487 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.485 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.485 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 3bx5 | 304 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.479 | |
| 3t2k | FAD | Sulfide-quinone reductase | / | 0.478 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.478 | |
| 4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.478 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.477 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.477 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.475 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
| 3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.473 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.472 | |
| 5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.472 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.471 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.470 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 4dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.467 | |
| 3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.467 | |
| 1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.466 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.466 | |
| 4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.466 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
| 2cmv | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.462 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
| 3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4l06 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.462 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.462 | |
| 1rbm | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.461 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
| 3lfa | 1N1 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3opd | HIE | Heat shock protein 83 | / | 0.461 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
| 1j39 | UPG | DNA beta-glucosyltransferase | / | 0.460 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
| 3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.460 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
| 3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
| 3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.458 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 1yqj | 6NP | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 1zmc | NAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.456 | |
| 2gst | GPS | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.456 | |
| 2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.456 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.456 | |
| 1u3d | FAD | Cryptochrome-1 | / | 0.455 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 2oz6 | CMP | Cyclic AMP receptor-like protein | / | 0.455 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.455 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
| 3vrw | YS5 | Vitamin D3 receptor | / | 0.454 | |
| 4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.454 | |
| 4l04 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.454 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.454 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.453 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.453 | |
| 3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 3fpj | SAM | Uncharacterized protein | / | 0.453 | |
| 3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.453 | |
| 4czt | CPS | CBL-interacting serine/threonine-protein kinase 23 | 2.7.11.1 | 0.453 | |
| 1w2x | RCP | Acetyl-CoA carboxylase | / | 0.452 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.452 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.452 | |
| 1ie8 | KH1 | Vitamin D3 receptor | / | 0.451 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.451 | |
| 4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
| 4jin | 1L7 | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.451 | |
| 1bsv | NDP | GDP-L-fucose synthase | / | 0.450 | |
| 1bve | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.450 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.450 | |
| 3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.449 | |
| 3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.449 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
| 4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.449 | |
| 1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.448 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 2baq | PQB | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.448 | |
| 2cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.448 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.448 | |
| 4c9o | CAM | Cytochrome P450 | / | 0.448 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
| 4ite | TEY | Vitamin D3 receptor | / | 0.448 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.448 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.447 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3qcx | 3Q2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.447 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.447 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.447 | |
| 1e7q | NAP | GDP-L-fucose synthase | / | 0.446 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.446 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3iod | A6D | Pantothenate synthetase | 6.3.2.1 | 0.446 | |
| 3iqe | F42 | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.446 | |
| 3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
| 5f8e | SAH | Possible transcriptional regulatory protein | / | 0.446 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.446 | |
| 2g5c | NAD | Prephenate dehydrogenase | / | 0.445 | |
| 2ktd | PUC | Prostaglandin-H2 D-isomerase | 5.3.99.2 | 0.445 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.445 | |
| 4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 5c8y | ACP | Tubulin tyrosine ligase | / | 0.445 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
| 2nu9 | COA | Succinate--CoA ligase [ADP-forming] subunit alpha | 6.2.1.5 | 0.444 | |
| 3och | 2MX | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 3p2o | NAD | Bifunctional protein FolD | / | 0.444 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.444 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.444 | |
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.444 | |
| 6gsx | GPS | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.444 | |
| 1ie3 | NAD | Malate dehydrogenase | / | 0.443 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.443 | |
| 2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.443 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.443 | |
| 4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 1u3c | FAD | Cryptochrome-1 | / | 0.442 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3ggg | NAD | Prephenate dehydrogenase | / | 0.442 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 4l03 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.442 | |
| 4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.442 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.442 | |
| 2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.441 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.441 | |
| 3da1 | FAD | Glycerol-3-phosphate dehydrogenase | / | 0.441 | |
| 3daf | FEG | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.441 | |
| 3haz | FAD | Bifunctional protein PutA | / | 0.441 | |
| 4qmu | SKE | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 1bws | NDP | GDP-L-fucose synthase | / | 0.440 | |
| 1lhv | NOG | Sex hormone-binding globulin | / | 0.440 | |
| 2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.440 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 2woe | AR6 | ADP-ribosyl-[dinitrogen reductase] glycohydrolase | 3.2.2.24 | 0.440 | |
| 2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.440 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3d5q | T30 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 3hja | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.440 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.440 | |
| 3tnl | NAD | Shikimate dehydrogenase (NADP(+)) | / | 0.440 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.440 | |
| 4ndn | SAM | S-adenosylmethionine synthase isoform type-2 | 2.5.1.6 | 0.440 |